| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |